Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[IgA nephropathy - research-generated questions].

Milan Raška, Josef Zadražil, Milada Stuchlová Horynová

    Vnitrni Lekarstvi
    |January 27, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transcriptomic Signatures of <i>Trichomonas vaginalis</i> Isolates That Exhibit Low, Intermediate, and High In Vitro Resistance to Metronidazole.

    Microorganisms·2026
    Same author

    Erratum to Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy.

    The Journal of clinical investigation·2026
    Same author

    Non-Genitally Stimulated Orgasms Increase Plasma Prolactin in a Menopausal Woman.

    International journal of sexual health : official journal of the World Association for Sexual Health·2026
    Same author

    The role of mucosal immune dysregulation in the pathogenesis of immunoglobulin A nephropathy.

    Frontiers in immunology·2026
    Same author

    Altered cytokinin signaling drives plant drought resilience through lipid remodeling, nutrient homeostasis, cell wall reinforcement, and modulation of biotic stress-associated pathways.

    Plant physiology and biochemistry : PPB·2026
    Same author

    Inhibition of p65 NF-κB enhances production of galactose-deficient IgA1 through suppression of <i>C1GALT1</i> and SP1 in plasmablast-like cell subpopulations.

    bioRxiv : the preprint server for biology·2026
    Same journal

    Pharmacological profile of mepolizumab.

    Vnitrni lekarstvi·2023
    Same journal

    Atypical form of Goodpasture's disease.

    Vnitrni lekarstvi·2023
    Same journal

    Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

    Vnitrni lekarstvi·2023
    Same journal

    Dyslipidemia - the known unknown.

    Vnitrni lekarstvi·2023
    Same journal

    Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

    Vnitrni lekarstvi·2023
    Same journal

    Implications of highly suppressive treatment HIV infection.

    Vnitrni lekarstvi·2023
    See all related articles

    IgA nephropathy (IgAN) is a kidney disease caused by abnormal immunoglobulin A1 (IgA1) proteins forming immune complexes. This leads to inflammation and potential kidney failure, necessitating targeted therapies.

    Area of Science:

    • Nephrology
    • Immunology
    • Pathology

    Background:

    • IgA nephropathy (IgAN) is the leading cause of glomerulonephritis worldwide.
    • Pathogenesis involves abnormal polymeric immunoglobulin A1 (IgA1) with altered glycosylation, leading to autoantibody formation and immune complex deposition in the kidney.
    • This immune response triggers mesangial cell inflammation, potentially causing end-stage kidney failure in up to 50% of patients.

    Purpose of the Study:

    • To explore the complex pathogenesis of IgA nephropathy.
    • To highlight the need for novel, targeted therapies addressing specific stages of IgAN development.
    • To identify gaps in current knowledge regarding the detailed mechanisms of IgAN.

    Main Methods:

    • Review of current literature on IgA nephropathy.

    Related Experiment Videos

  • Analysis of the role of immunoglobulin A1 (IgA1) glycosylation in disease development.
  • Discussion of genetic and environmental factors contributing to IgAN.

    • Main Results:

    • Abnormal IgA1 glycosylation is a key factor in IgAN etiology.
    • Immune complex formation and mesangial inflammation are central to disease progression.
    • Current treatments are insufficient, underscoring the need for etiological therapies.

    Conclusions:

    • IgA nephropathy pathogenesis is multifactorial, involving genetic and environmental triggers.
    • Targeting abnormal IgA1 and the subsequent immune response offers potential therapeutic strategies.
    • Further research is crucial to elucidate detailed pathological mechanisms and develop effective treatments for IgAN.